Security key
74365U107
Protara Therapeutics, Inc. - Common Stock (TARA)
CUSIP: 74365U107
Q3 2020 13F Holders as of 30 Sep 2020
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 9,281,283
- Total 13F value
- $156,208,097
- Share change
- +5,461,011
- SEC-reported price per share
- $16.83
- Number of holders
- 44
- Value change
- +$91,825,921
- Number of buys
- 30
- Number of sells
- 9
- Shares outstanding
- 55,913,202
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2020
Institutions
44
Top holders
10
TARA full security history
Ownership snapshot
Full 13F holder table
Protara Therapeutics, Inc. SEC filings
Protara Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of TARA - Protara Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Opaleye Management Inc.
Disclosed value leader
Opaleye Management Inc.
Comparable rows
0/15
Latest evidence
30 Jun 2020
13F
Highest disclosed value: $64,752,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Opaleye Management Inc. has the largest disclosed position value at $64.75M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Opaleye Management Inc.'s linked filing trail.
Disclosed position value
Top 5
Opaleye Management Inc.
$64.75M
Ikarian Capital, LLC
$15.48M
DEERFIELD MANAGEMENT COMPANY, L.P.
$12.69M
Boxer Capital, LLC
$6.14M
BAKER BROS. ADVISORS LP
$5.85M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Opaleye Management Inc. |
13F
Company
|
—
denominator unverified
|
$64,752,000
2,208,472 shares
|
— | 30 Jun 2020 |
| Ikarian Capital, LLC |
13F
Company
|
—
denominator unverified
|
$15,480,000
527,964 shares
|
— | 30 Jun 2020 |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
Company
|
—
denominator unverified
|
$12,686,000
432,670 shares
|
— | 30 Jun 2020 |
| Boxer Capital, LLC |
13F
Company
|
—
denominator unverified
|
$6,135,000
209,227 shares
|
— | 30 Jun 2020 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
—
denominator unverified
|
$5,854,000
199,671 shares
|
— | 30 Jun 2020 |
| Abingworth LLP |
13F
Company
|
—
denominator unverified
|
$3,001,000
53,612 shares
|
— | 30 Jun 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
44
Shares
9,281,283
Rows available
44
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2020 vs Q2 2020 Across Filers
Q2 2020 holders
31
Q3 2020 holders
44
Holder diff
13
| Investor | Q2 2020 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q2 2020 value | Q3 2020 value | Value change | Value Chg % |
|---|